RecallDepth
Class III Terminated

Norpace CR (disopyramide phosphate) extended-release capsules USP,150 mg, packaged in a) 100-count bottles (NDC 0025-2742-31), and b) 500-count bottles (NDC 0025-2742-51), Rx only, Distributed by G.D. Searle LLC, Division of Pfizer Inc, NY, NY 10017.

This recall has been terminated (originally issued December 16, 2015).

Company
Pfizer Inc.
Recall Initiated
December 2, 2015
Posted
December 16, 2015
Recall Number
D-0520-2016
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
a) 4005 bottles, b) 104 bottles
Firm Location
New York, NY, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Dissolution Specification

Distribution

Nationwide

Lot / Code Info

Lot #: C150065; C150064, Exp 6/16

More recalls by Pfizer Inc.

View all recalls by this company →

Other recent Class III Drug recalls